Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) — The “Nuclear Imaging Equipment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” has been added to ResearchAndMarkets.com’s offering.
The Global Nuclear Imaging Equipment Market, valued at USD 3.89 Billion in 2024, is projected to experience a CAGR of 8.10% to reach USD 6.21 Billion by 2030.
The market’s growth is propelled by the increasing global prevalence of chronic diseases, a sustained demand for early and accurate diagnostic tools, and ongoing technological advancements, including the development of hybrid imaging modalities. The Global Nuclear Imaging Equipment Market has been segmented into the following categories:
By Product Type:
- PET Imaging Systems
- Gamma Camera Imaging Systems
By Application:
- Oncology
- Cardiology
- Neurology
- Others
By End User:
- Hospitals & Clinics
- Diagnostic Imaging Centers
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Market Drivers
The increasing prevalence of chronic diseases serves as a primary driver for the Global Nuclear Imaging Equipment Market. Conditions like cancer, cardiovascular ailments, and neurological disorders require advanced diagnostic tools for early detection, accurate staging, and effective treatment monitoring. Nuclear imaging provides essential physiological and metabolic information vital for managing these complex health challenges.
According to the World Health Organization’s International Agency for Research on Cancer (IARC), in February 2024, an estimated 20 million new cancer cases were recorded worldwide in 2022, highlighting the substantial patient demographic necessitating precise diagnostic evaluations. This escalating disease burden fuels a sustained demand for sophisticated nuclear imaging equipment across global healthcare infrastructures.
Key Market Challenges
The considerable capital investment required for nuclear imaging equipment directly hampers the growth of the Global Nuclear Imaging Equipment Market. This significant economic barrier encompasses the costs associated with equipment procurement, complex installation processes, and continuous operational maintenance. Such high financial outlay restricts the wider adoption of these advanced diagnostic tools, particularly within healthcare systems of developing regions where budgetary constraints are more pronounced.
Key Market Trends
The emergence of theranostics represents a significant trend within the global nuclear imaging equipment market, shifting the paradigm from purely diagnostic imaging to an integrated approach combining both diagnosis and targeted therapy. This methodology utilizes specific radiopharmaceuticals to identify disease at a molecular level and subsequently deliver a therapeutic dose to the identified target, minimizing impact on healthy tissue. This integration enables highly personalized patient management, particularly in oncology and other complex diseases.
Key Market Players Profiled:
- Siemens Healthineers AG
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- SurgicEye GmbH
- Mediso Ltd.
- MR Solutions Ltd.
- Segami Corporation
- Mirion Technologies (Capintec), Inc.
- Neusoft Medical Systems Co., Ltd.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $3.89 Billion |
| Forecasted Market Value (USD) by 2030 | $6.21 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/dibryl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Nuclear Imaging Equipment Market
